Atlas Trials

A Phase-II Study Of TOMUDEX Plus Radiotherapy In Subject With Inoperable or Recurrent Rectal Cancer

Clinical trial NCT00590278 · COMPLETED

Trial details

NCT number
NCT00590278
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Inoperable or Recurrent Rectal Cancer
Start date
2002-08-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.